Grandfield & Dodd »

Intellia Therapeutics shares owned by Grandfield & Dodd

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Grandfield & Dodd from 13F filings

Historical chart of Grandfield & Dodd investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Grandfield & Dodd consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Grandfield & Dodd

Quarter filed Position value Share count Share price at filing
2025-09-30 $877k 51k 17.27
2025-06-30 $457k 49k 9.38
2025-03-31 $346k 49k 7.11
2024-12-31 $363k 31k 11.66
2024-09-30 $267k 13k 20.55